158 related articles for article (PubMed ID: 4302048)
1. [Studies on the oxido-reductive reaction in the cerebrospinal fluid].
Rymczonek C
Neurol Neurochir Pol; 1968; 2(4):485-90. PubMed ID: 4302048
[No Abstract] [Full Text] [Related]
2. Cerebrospinal fluid lactate dehydrogenase in neurological patients.
Hardy JS; Holmes JE
Bull Los Angeles Neurol Soc; 1967 Oct; 32(4):208-12. PubMed ID: 6056724
[No Abstract] [Full Text] [Related]
3. [Diagnostic value of quantitative and qualitative variations in cerebrospinal fluid proteins].
Olischer RM
Psychiatr Neurol Med Psychol (Leipz); 1977 Aug; 29(8):449-64. PubMed ID: 73198
[TBL] [Abstract][Full Text] [Related]
4. [Immunologic study of the cerebrospinal fluid proteins].
Maravi E; Artieda P; Lopez-Borrasca A; Martinez-Lage JM
Rev Neurol (Paris); 1967 Oct; 117(4):586-7. PubMed ID: 4304315
[No Abstract] [Full Text] [Related]
5. 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of patients with neurological diseases.
Johannsson B; Roos BE
Eur Neurol; 1974; 11(1):37-45. PubMed ID: 4363875
[No Abstract] [Full Text] [Related]
6. Cerebrospinal fluid proteins and serum immunoglobulins. Occurrence in multiple sclerosis and other neurological diseases: comparative measurement of gamma-globulin and the IgG class.
Fischer-Williams M; Roberts RC
Arch Neurol; 1971 Dec; 25(6):526-34. PubMed ID: 4107216
[No Abstract] [Full Text] [Related]
7. [Quantitative determination of GPT, GOT and LDH in the cerebrospinal fluid as an aid in the diagnosis of the kind of neurologic disease].
Braun H; Ley H
Munch Med Wochenschr; 1966 Aug; 108(32):1562-6. PubMed ID: 6014384
[No Abstract] [Full Text] [Related]
8. [Cerebrospinal fluid protein].
Igata A
Naika; 1969 Jul; 24(1):105-9. PubMed ID: 5805506
[No Abstract] [Full Text] [Related]
9. [Introduction and application of CSF cytology for diagnosis and treatment of central nervous system diseases].
Su XC; Zhao G; Yang YN; Deng YC
Acta Neurol Taiwan; 2006 Jun; 15(2):143-8. PubMed ID: 16871902
[No Abstract] [Full Text] [Related]
10. [The gamma globulins of the cerebrospinal fluid in multiple sclerosis].
Laterre EC
Acta Neurol Psychiatr Belg; 1966 Apr; 66(4):305-18. PubMed ID: 4162680
[No Abstract] [Full Text] [Related]
11. [Changes of the fatty acids in cerebrospinal fluid in pathological conditions: characteristics of some lipid and lipoprotein fractions].
Arnetoli G; Cadelo M; Taiuti R; Amaducci L
Acta Neurol (Napoli); 1972; 27(2):114-20. PubMed ID: 5042256
[No Abstract] [Full Text] [Related]
12. [New research methods in cerebrospinal fluid diagnosis].
Schmidt RM
Dtsch Gesundheitsw; 1969 Feb; 24(7):289-96. PubMed ID: 4916949
[No Abstract] [Full Text] [Related]
13. [The so-called paralysis curve of the goldsol reaction in nonsyphiliic neuropathies].
Grahmann H
Nervenarzt; 1969 Feb; 40(2):92-5. PubMed ID: 4312052
[No Abstract] [Full Text] [Related]
14. [On the method of ultraviolet spectrophotometry of cerebrospinal fluid].
Brio AN
Lab Delo; 1969; 1():41-2. PubMed ID: 4185359
[No Abstract] [Full Text] [Related]
15. Adenosine deaminase in cerebrospinal fluid.
Hankiewicz J; Lesniak M
Enzymologia; 1972 Dec; 43(6):385-95. PubMed ID: 4646287
[No Abstract] [Full Text] [Related]
16. Para-albumins in cerebrospinal fluid.
Kolar OJ; Ross AT; Herman JT
Neurology; 1969 Sep; 19(9):826-33. PubMed ID: 5816875
[No Abstract] [Full Text] [Related]
17. [Cerebrospinal fluid cytology. A meaningful routine procedure in cerebrospinal fluid diagnosis].
Schulte RM
Med Welt; 1982 Oct; 33(43):1504-7. PubMed ID: 7154922
[No Abstract] [Full Text] [Related]
18. The clinical value of assaying proteins in the cerebrospinal fluid. A comparative study in methods.
Clausen J; Fog T; Einstein ER
Acta Neurol Scand; 1969; 45(5):513-28. PubMed ID: 4189364
[No Abstract] [Full Text] [Related]
19. [Neurological complications associated with paraproteinaemic hemoblastoses (author's transl)].
Prange H; Kaboth U; Spaar FW; Gremse B
Fortschr Neurol Psychiatr Grenzgeb; 1979 Aug; 47(8):387-98. PubMed ID: 225248
[No Abstract] [Full Text] [Related]
20. Cerebrospinal fluid electrolyte disturbances in neurological disorders: with special reference to inorganic phosphate.
Breyer U; Kanig K
Neurology; 1970 Mar; 20(3):247-53. PubMed ID: 5461053
[No Abstract] [Full Text] [Related]
[Next] [New Search]
